<i>NEDD9</i>, an independent good prognostic factor in intermediate-risk acute myeloid leukemia patients.

Oncotarget · 2017 · PMC5652681 · PMID 29100287

Europe PMC DOI

hedged sentences

0.0560

closest p · 1.1× alpha

0.0670

boldest claim

The sentences

a clear trendp = 0.056so close (0.05 < p ≤ 0.1)

In addition, in the Cohort 1 patients with NEDD9 overexpression showed a clear trend towards significance in predicting better DFS (70.1 ± 12.6 vs 39.0 ± 8.8%, p = 0.056) (Figure 1 ).

also in 19,460 other papers

a trend towards significancep = 0.067so close (0.05 < p ≤ 0.1)

Regarding DFS, only NEDD9 expression showed a trend towards significance ( p = 0.067) while any variable was significant in the CIR univariate analyses.

also in 2,760 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.